nodes	percent_of_prediction	percent_of_DWPC	metapath
Mirtazapine—CYP2C8—Tamoxifen—pancreatic cancer	0.0392	0.101	CbGbCtD
Mirtazapine—CYP1A2—Dacarbazine—pancreatic cancer	0.0381	0.0982	CbGbCtD
Mirtazapine—CYP2C8—Erlotinib—pancreatic cancer	0.0333	0.0858	CbGbCtD
Mirtazapine—CYP1A2—Tamoxifen—pancreatic cancer	0.0303	0.0781	CbGbCtD
Mirtazapine—CYP2C8—Fluorouracil—pancreatic cancer	0.0289	0.0744	CbGbCtD
Mirtazapine—CYP2C9—Tamoxifen—pancreatic cancer	0.0273	0.0704	CbGbCtD
Mirtazapine—CYP1A2—Erlotinib—pancreatic cancer	0.0258	0.0664	CbGbCtD
Mirtazapine—CYP2D6—Tamoxifen—pancreatic cancer	0.025	0.0644	CbGbCtD
Mirtazapine—CYP1A2—Fluorouracil—pancreatic cancer	0.0223	0.0576	CbGbCtD
Mirtazapine—CYP2D6—Erlotinib—pancreatic cancer	0.0212	0.0547	CbGbCtD
Mirtazapine—HTR3A—enteric nervous system—pancreatic cancer	0.0211	0.368	CbGeAlD
Mirtazapine—CYP2C9—Fluorouracil—pancreatic cancer	0.0201	0.0519	CbGbCtD
Mirtazapine—CYP3A4—Tamoxifen—pancreatic cancer	0.0159	0.0409	CbGbCtD
Mirtazapine—HTR7—enteric nervous system—pancreatic cancer	0.0136	0.238	CbGeAlD
Mirtazapine—CYP3A4—Erlotinib—pancreatic cancer	0.0135	0.0348	CbGbCtD
Mirtazapine—CYP3A4—Irinotecan—pancreatic cancer	0.0122	0.0314	CbGbCtD
Mirtazapine—CYP2D6—Doxorubicin—pancreatic cancer	0.0105	0.027	CbGbCtD
Mirtazapine—CYP3A4—Docetaxel—pancreatic cancer	0.00894	0.023	CbGbCtD
Mirtazapine—CYP3A4—Sunitinib—pancreatic cancer	0.0089	0.0229	CbGbCtD
Mirtazapine—HTR2A—enteric nervous system—pancreatic cancer	0.00851	0.149	CbGeAlD
Mirtazapine—CYP3A4—Doxorubicin—pancreatic cancer	0.00666	0.0172	CbGbCtD
Mirtazapine—HRH3—digestive system—pancreatic cancer	0.00252	0.0441	CbGeAlD
Mirtazapine—HTR3A—islet of Langerhans—pancreatic cancer	0.00202	0.0352	CbGeAlD
Mirtazapine—HTR3A—digestive system—pancreatic cancer	0.00121	0.0211	CbGeAlD
Mirtazapine—ADRA2A—islet of Langerhans—pancreatic cancer	0.000956	0.0167	CbGeAlD
Mirtazapine—SLC6A4—digestive system—pancreatic cancer	0.000923	0.0161	CbGeAlD
Mirtazapine—HTR2B—digestive system—pancreatic cancer	0.000914	0.016	CbGeAlD
Mirtazapine—ADRA2C—pancreas—pancreatic cancer	0.000843	0.0147	CbGeAlD
Mirtazapine—HTR7—digestive system—pancreatic cancer	0.000783	0.0137	CbGeAlD
Mirtazapine—ADRA2A—pancreas—pancreatic cancer	0.000672	0.0117	CbGeAlD
Mirtazapine—CYP1A2—digestive system—pancreatic cancer	0.000624	0.0109	CbGeAlD
Mirtazapine—CYP2C9—digestive system—pancreatic cancer	0.000593	0.0103	CbGeAlD
Mirtazapine—HRH1—digestive system—pancreatic cancer	0.000585	0.0102	CbGeAlD
Mirtazapine—HTR2A—digestive system—pancreatic cancer	0.000488	0.00852	CbGeAlD
Mirtazapine—CYP3A4—digestive system—pancreatic cancer	0.000452	0.00789	CbGeAlD
Mirtazapine—CYP2D6—digestive system—pancreatic cancer	0.000445	0.00777	CbGeAlD
Mirtazapine—Pancytopenia—Doxorubicin—pancreatic cancer	0.000157	0.000462	CcSEcCtD
Mirtazapine—Asthenia—Irinotecan—pancreatic cancer	0.000157	0.00046	CcSEcCtD
Mirtazapine—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—pancreatic cancer	0.000156	0.000459	CcSEcCtD
Mirtazapine—Stomatitis—Epirubicin—pancreatic cancer	0.000155	0.000457	CcSEcCtD
Mirtazapine—Jaundice—Epirubicin—pancreatic cancer	0.000155	0.000457	CcSEcCtD
Mirtazapine—Urinary tract infection—Epirubicin—pancreatic cancer	0.000155	0.000456	CcSEcCtD
Mirtazapine—Conjunctivitis—Epirubicin—pancreatic cancer	0.000155	0.000456	CcSEcCtD
Mirtazapine—Dysuria—Doxorubicin—pancreatic cancer	0.000155	0.000455	CcSEcCtD
Mirtazapine—Neutropenia—Doxorubicin—pancreatic cancer	0.000155	0.000455	CcSEcCtD
Mirtazapine—Hypersensitivity—Fluorouracil—pancreatic cancer	0.000154	0.000452	CcSEcCtD
Mirtazapine—Dry mouth—Docetaxel—pancreatic cancer	0.000154	0.000452	CcSEcCtD
Mirtazapine—Sweating—Epirubicin—pancreatic cancer	0.000153	0.000449	CcSEcCtD
Mirtazapine—Pollakiuria—Doxorubicin—pancreatic cancer	0.000153	0.000449	CcSEcCtD
Mirtazapine—Asthenia—Gemcitabine—pancreatic cancer	0.000153	0.000448	CcSEcCtD
Mirtazapine—Haematuria—Epirubicin—pancreatic cancer	0.000152	0.000447	CcSEcCtD
Mirtazapine—Confusional state—Docetaxel—pancreatic cancer	0.000152	0.000447	CcSEcCtD
Mirtazapine—Photosensitivity reaction—Doxorubicin—pancreatic cancer	0.000151	0.000444	CcSEcCtD
Mirtazapine—Hepatobiliary disease—Epirubicin—pancreatic cancer	0.000151	0.000443	CcSEcCtD
Mirtazapine—Oedema—Docetaxel—pancreatic cancer	0.000151	0.000443	CcSEcCtD
Mirtazapine—Weight increased—Doxorubicin—pancreatic cancer	0.000151	0.000443	CcSEcCtD
Mirtazapine—Epistaxis—Epirubicin—pancreatic cancer	0.00015	0.000442	CcSEcCtD
Mirtazapine—Pruritus—Gemcitabine—pancreatic cancer	0.00015	0.000442	CcSEcCtD
Mirtazapine—Infection—Docetaxel—pancreatic cancer	0.00015	0.00044	CcSEcCtD
Mirtazapine—Weight decreased—Doxorubicin—pancreatic cancer	0.00015	0.00044	CcSEcCtD
Mirtazapine—Sinusitis—Epirubicin—pancreatic cancer	0.00015	0.00044	CcSEcCtD
Mirtazapine—Diarrhoea—Irinotecan—pancreatic cancer	0.000149	0.000439	CcSEcCtD
Mirtazapine—Agranulocytosis—Epirubicin—pancreatic cancer	0.000149	0.000437	CcSEcCtD
Mirtazapine—Pneumonia—Doxorubicin—pancreatic cancer	0.000148	0.000436	CcSEcCtD
Mirtazapine—Shock—Docetaxel—pancreatic cancer	0.000148	0.000436	CcSEcCtD
Mirtazapine—Nervous system disorder—Docetaxel—pancreatic cancer	0.000148	0.000435	CcSEcCtD
Mirtazapine—Pruritus—Fluorouracil—pancreatic cancer	0.000148	0.000434	CcSEcCtD
Mirtazapine—Thrombocytopenia—Docetaxel—pancreatic cancer	0.000148	0.000434	CcSEcCtD
Mirtazapine—Drowsiness—Doxorubicin—pancreatic cancer	0.000148	0.000434	CcSEcCtD
Mirtazapine—Tachycardia—Docetaxel—pancreatic cancer	0.000147	0.000433	CcSEcCtD
Mirtazapine—Skin disorder—Docetaxel—pancreatic cancer	0.000147	0.000431	CcSEcCtD
Mirtazapine—Stevens-Johnson syndrome—Doxorubicin—pancreatic cancer	0.000146	0.00043	CcSEcCtD
Mirtazapine—Bradycardia—Epirubicin—pancreatic cancer	0.000146	0.000428	CcSEcCtD
Mirtazapine—Diarrhoea—Gemcitabine—pancreatic cancer	0.000145	0.000427	CcSEcCtD
Mirtazapine—Dizziness—Irinotecan—pancreatic cancer	0.000144	0.000424	CcSEcCtD
Mirtazapine—Stomatitis—Doxorubicin—pancreatic cancer	0.000144	0.000423	CcSEcCtD
Mirtazapine—Jaundice—Doxorubicin—pancreatic cancer	0.000144	0.000423	CcSEcCtD
Mirtazapine—Anorexia—Docetaxel—pancreatic cancer	0.000144	0.000422	CcSEcCtD
Mirtazapine—Rhinitis—Epirubicin—pancreatic cancer	0.000144	0.000422	CcSEcCtD
Mirtazapine—Urinary tract infection—Doxorubicin—pancreatic cancer	0.000143	0.000422	CcSEcCtD
Mirtazapine—Conjunctivitis—Doxorubicin—pancreatic cancer	0.000143	0.000422	CcSEcCtD
Mirtazapine—Hepatitis—Epirubicin—pancreatic cancer	0.000143	0.000421	CcSEcCtD
Mirtazapine—Diarrhoea—Fluorouracil—pancreatic cancer	0.000143	0.00042	CcSEcCtD
Mirtazapine—Hypoaesthesia—Epirubicin—pancreatic cancer	0.000142	0.000419	CcSEcCtD
Mirtazapine—Pharyngitis—Epirubicin—pancreatic cancer	0.000142	0.000418	CcSEcCtD
Mirtazapine—Sweating—Doxorubicin—pancreatic cancer	0.000142	0.000416	CcSEcCtD
Mirtazapine—Urinary tract disorder—Epirubicin—pancreatic cancer	0.000141	0.000416	CcSEcCtD
Mirtazapine—Oedema peripheral—Epirubicin—pancreatic cancer	0.000141	0.000415	CcSEcCtD
Mirtazapine—Hypotension—Docetaxel—pancreatic cancer	0.000141	0.000414	CcSEcCtD
Mirtazapine—Haematuria—Doxorubicin—pancreatic cancer	0.000141	0.000414	CcSEcCtD
Mirtazapine—Urethral disorder—Epirubicin—pancreatic cancer	0.00014	0.000412	CcSEcCtD
Mirtazapine—Hepatobiliary disease—Doxorubicin—pancreatic cancer	0.00014	0.00041	CcSEcCtD
Mirtazapine—Epistaxis—Doxorubicin—pancreatic cancer	0.000139	0.000409	CcSEcCtD
Mirtazapine—Vomiting—Irinotecan—pancreatic cancer	0.000139	0.000408	CcSEcCtD
Mirtazapine—Sinusitis—Doxorubicin—pancreatic cancer	0.000138	0.000407	CcSEcCtD
Mirtazapine—Dizziness—Fluorouracil—pancreatic cancer	0.000138	0.000406	CcSEcCtD
Mirtazapine—Agranulocytosis—Doxorubicin—pancreatic cancer	0.000138	0.000405	CcSEcCtD
Mirtazapine—Rash—Irinotecan—pancreatic cancer	0.000138	0.000404	CcSEcCtD
Mirtazapine—Dermatitis—Irinotecan—pancreatic cancer	0.000137	0.000404	CcSEcCtD
Mirtazapine—Musculoskeletal discomfort—Docetaxel—pancreatic cancer	0.000137	0.000404	CcSEcCtD
Mirtazapine—Headache—Irinotecan—pancreatic cancer	0.000137	0.000402	CcSEcCtD
Mirtazapine—Insomnia—Docetaxel—pancreatic cancer	0.000136	0.000401	CcSEcCtD
Mirtazapine—Paraesthesia—Docetaxel—pancreatic cancer	0.000135	0.000398	CcSEcCtD
Mirtazapine—Erythema multiforme—Epirubicin—pancreatic cancer	0.000135	0.000398	CcSEcCtD
Mirtazapine—Vomiting—Gemcitabine—pancreatic cancer	0.000135	0.000397	CcSEcCtD
Mirtazapine—Bradycardia—Doxorubicin—pancreatic cancer	0.000135	0.000396	CcSEcCtD
Mirtazapine—Dyspnoea—Docetaxel—pancreatic cancer	0.000134	0.000395	CcSEcCtD
Mirtazapine—Somnolence—Docetaxel—pancreatic cancer	0.000134	0.000394	CcSEcCtD
Mirtazapine—Rash—Gemcitabine—pancreatic cancer	0.000134	0.000394	CcSEcCtD
Mirtazapine—Dermatitis—Gemcitabine—pancreatic cancer	0.000134	0.000393	CcSEcCtD
Mirtazapine—Eye disorder—Epirubicin—pancreatic cancer	0.000134	0.000393	CcSEcCtD
Mirtazapine—Tinnitus—Epirubicin—pancreatic cancer	0.000134	0.000392	CcSEcCtD
Mirtazapine—Headache—Gemcitabine—pancreatic cancer	0.000133	0.000391	CcSEcCtD
Mirtazapine—Cardiac disorder—Epirubicin—pancreatic cancer	0.000133	0.000391	CcSEcCtD
Mirtazapine—Vomiting—Fluorouracil—pancreatic cancer	0.000133	0.00039	CcSEcCtD
Mirtazapine—Rhinitis—Doxorubicin—pancreatic cancer	0.000133	0.00039	CcSEcCtD
Mirtazapine—Dyspepsia—Docetaxel—pancreatic cancer	0.000133	0.00039	CcSEcCtD
Mirtazapine—Hepatitis—Doxorubicin—pancreatic cancer	0.000133	0.000389	CcSEcCtD
Mirtazapine—Hypoaesthesia—Doxorubicin—pancreatic cancer	0.000132	0.000387	CcSEcCtD
Mirtazapine—Rash—Fluorouracil—pancreatic cancer	0.000132	0.000387	CcSEcCtD
Mirtazapine—Dermatitis—Fluorouracil—pancreatic cancer	0.000132	0.000387	CcSEcCtD
Mirtazapine—Pharyngitis—Doxorubicin—pancreatic cancer	0.000132	0.000386	CcSEcCtD
Mirtazapine—Decreased appetite—Docetaxel—pancreatic cancer	0.000131	0.000385	CcSEcCtD
Mirtazapine—Headache—Fluorouracil—pancreatic cancer	0.000131	0.000385	CcSEcCtD
Mirtazapine—Urinary tract disorder—Doxorubicin—pancreatic cancer	0.000131	0.000385	CcSEcCtD
Mirtazapine—Oedema peripheral—Doxorubicin—pancreatic cancer	0.000131	0.000384	CcSEcCtD
Mirtazapine—Gastrointestinal disorder—Docetaxel—pancreatic cancer	0.00013	0.000383	CcSEcCtD
Mirtazapine—Fatigue—Docetaxel—pancreatic cancer	0.00013	0.000382	CcSEcCtD
Mirtazapine—Angiopathy—Epirubicin—pancreatic cancer	0.00013	0.000382	CcSEcCtD
Mirtazapine—Urethral disorder—Doxorubicin—pancreatic cancer	0.00013	0.000382	CcSEcCtD
Mirtazapine—Nausea—Irinotecan—pancreatic cancer	0.00013	0.000381	CcSEcCtD
Mirtazapine—Constipation—Docetaxel—pancreatic cancer	0.000129	0.000379	CcSEcCtD
Mirtazapine—Pain—Docetaxel—pancreatic cancer	0.000129	0.000379	CcSEcCtD
Mirtazapine—Chills—Epirubicin—pancreatic cancer	0.000128	0.000378	CcSEcCtD
Mirtazapine—Arrhythmia—Epirubicin—pancreatic cancer	0.000128	0.000376	CcSEcCtD
Mirtazapine—Alopecia—Epirubicin—pancreatic cancer	0.000127	0.000372	CcSEcCtD
Mirtazapine—Nausea—Gemcitabine—pancreatic cancer	0.000126	0.000371	CcSEcCtD
Mirtazapine—Mental disorder—Epirubicin—pancreatic cancer	0.000125	0.000369	CcSEcCtD
Mirtazapine—Erythema multiforme—Doxorubicin—pancreatic cancer	0.000125	0.000368	CcSEcCtD
Mirtazapine—Malnutrition—Epirubicin—pancreatic cancer	0.000125	0.000366	CcSEcCtD
Mirtazapine—Feeling abnormal—Docetaxel—pancreatic cancer	0.000124	0.000365	CcSEcCtD
Mirtazapine—Nausea—Fluorouracil—pancreatic cancer	0.000124	0.000365	CcSEcCtD
Mirtazapine—Eye disorder—Doxorubicin—pancreatic cancer	0.000124	0.000364	CcSEcCtD
Mirtazapine—Tinnitus—Doxorubicin—pancreatic cancer	0.000124	0.000363	CcSEcCtD
Mirtazapine—Gastrointestinal pain—Docetaxel—pancreatic cancer	0.000123	0.000362	CcSEcCtD
Mirtazapine—Cardiac disorder—Doxorubicin—pancreatic cancer	0.000123	0.000361	CcSEcCtD
Mirtazapine—Flatulence—Epirubicin—pancreatic cancer	0.000123	0.000361	CcSEcCtD
Mirtazapine—Tension—Epirubicin—pancreatic cancer	0.000122	0.000359	CcSEcCtD
Mirtazapine—Dysgeusia—Epirubicin—pancreatic cancer	0.000122	0.000359	CcSEcCtD
Mirtazapine—Nervousness—Epirubicin—pancreatic cancer	0.000121	0.000356	CcSEcCtD
Mirtazapine—Back pain—Epirubicin—pancreatic cancer	0.000121	0.000354	CcSEcCtD
Mirtazapine—Angiopathy—Doxorubicin—pancreatic cancer	0.00012	0.000353	CcSEcCtD
Mirtazapine—Abdominal pain—Docetaxel—pancreatic cancer	0.000119	0.00035	CcSEcCtD
Mirtazapine—Body temperature increased—Docetaxel—pancreatic cancer	0.000119	0.00035	CcSEcCtD
Mirtazapine—Chills—Doxorubicin—pancreatic cancer	0.000119	0.000349	CcSEcCtD
Mirtazapine—Arrhythmia—Doxorubicin—pancreatic cancer	0.000118	0.000348	CcSEcCtD
Mirtazapine—Alopecia—Doxorubicin—pancreatic cancer	0.000117	0.000344	CcSEcCtD
Mirtazapine—Mental disorder—Doxorubicin—pancreatic cancer	0.000116	0.000341	CcSEcCtD
Mirtazapine—Ill-defined disorder—Epirubicin—pancreatic cancer	0.000116	0.00034	CcSEcCtD
Mirtazapine—Malnutrition—Doxorubicin—pancreatic cancer	0.000115	0.000339	CcSEcCtD
Mirtazapine—Anaemia—Epirubicin—pancreatic cancer	0.000115	0.000339	CcSEcCtD
Mirtazapine—Agitation—Epirubicin—pancreatic cancer	0.000115	0.000337	CcSEcCtD
Mirtazapine—Flatulence—Doxorubicin—pancreatic cancer	0.000114	0.000334	CcSEcCtD
Mirtazapine—Tension—Doxorubicin—pancreatic cancer	0.000113	0.000333	CcSEcCtD
Mirtazapine—Dysgeusia—Doxorubicin—pancreatic cancer	0.000113	0.000332	CcSEcCtD
Mirtazapine—Malaise—Epirubicin—pancreatic cancer	0.000112	0.00033	CcSEcCtD
Mirtazapine—Nervousness—Doxorubicin—pancreatic cancer	0.000112	0.000329	CcSEcCtD
Mirtazapine—Vertigo—Epirubicin—pancreatic cancer	0.000112	0.000329	CcSEcCtD
Mirtazapine—Syncope—Epirubicin—pancreatic cancer	0.000112	0.000329	CcSEcCtD
Mirtazapine—Leukopenia—Epirubicin—pancreatic cancer	0.000112	0.000328	CcSEcCtD
Mirtazapine—Back pain—Doxorubicin—pancreatic cancer	0.000112	0.000328	CcSEcCtD
Mirtazapine—Hypersensitivity—Docetaxel—pancreatic cancer	0.000111	0.000327	CcSEcCtD
Mirtazapine—Palpitations—Epirubicin—pancreatic cancer	0.00011	0.000324	CcSEcCtD
Mirtazapine—Loss of consciousness—Epirubicin—pancreatic cancer	0.00011	0.000322	CcSEcCtD
Mirtazapine—Cough—Epirubicin—pancreatic cancer	0.000109	0.00032	CcSEcCtD
Mirtazapine—Asthenia—Docetaxel—pancreatic cancer	0.000108	0.000318	CcSEcCtD
Mirtazapine—Convulsion—Epirubicin—pancreatic cancer	0.000108	0.000317	CcSEcCtD
Mirtazapine—Hypertension—Epirubicin—pancreatic cancer	0.000108	0.000316	CcSEcCtD
Mirtazapine—Ill-defined disorder—Doxorubicin—pancreatic cancer	0.000107	0.000314	CcSEcCtD
Mirtazapine—Pruritus—Docetaxel—pancreatic cancer	0.000107	0.000314	CcSEcCtD
Mirtazapine—Anaemia—Doxorubicin—pancreatic cancer	0.000107	0.000313	CcSEcCtD
Mirtazapine—Arthralgia—Epirubicin—pancreatic cancer	0.000106	0.000312	CcSEcCtD
Mirtazapine—Myalgia—Epirubicin—pancreatic cancer	0.000106	0.000312	CcSEcCtD
Mirtazapine—Chest pain—Epirubicin—pancreatic cancer	0.000106	0.000312	CcSEcCtD
Mirtazapine—Agitation—Doxorubicin—pancreatic cancer	0.000106	0.000311	CcSEcCtD
Mirtazapine—Anxiety—Epirubicin—pancreatic cancer	0.000106	0.000311	CcSEcCtD
Mirtazapine—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—pancreatic cancer	0.000105	0.00031	CcSEcCtD
Mirtazapine—Discomfort—Epirubicin—pancreatic cancer	0.000105	0.000308	CcSEcCtD
Mirtazapine—Malaise—Doxorubicin—pancreatic cancer	0.000104	0.000306	CcSEcCtD
Mirtazapine—Dry mouth—Epirubicin—pancreatic cancer	0.000104	0.000305	CcSEcCtD
Mirtazapine—Vertigo—Doxorubicin—pancreatic cancer	0.000104	0.000305	CcSEcCtD
Mirtazapine—Syncope—Doxorubicin—pancreatic cancer	0.000103	0.000304	CcSEcCtD
Mirtazapine—Leukopenia—Doxorubicin—pancreatic cancer	0.000103	0.000303	CcSEcCtD
Mirtazapine—Diarrhoea—Docetaxel—pancreatic cancer	0.000103	0.000303	CcSEcCtD
Mirtazapine—Confusional state—Epirubicin—pancreatic cancer	0.000103	0.000301	CcSEcCtD
Mirtazapine—Palpitations—Doxorubicin—pancreatic cancer	0.000102	0.0003	CcSEcCtD
Mirtazapine—Oedema—Epirubicin—pancreatic cancer	0.000102	0.000299	CcSEcCtD
Mirtazapine—Loss of consciousness—Doxorubicin—pancreatic cancer	0.000101	0.000298	CcSEcCtD
Mirtazapine—Infection—Epirubicin—pancreatic cancer	0.000101	0.000297	CcSEcCtD
Mirtazapine—Cough—Doxorubicin—pancreatic cancer	0.000101	0.000296	CcSEcCtD
Mirtazapine—Shock—Epirubicin—pancreatic cancer	0.0001	0.000294	CcSEcCtD
Mirtazapine—Convulsion—Doxorubicin—pancreatic cancer	9.99e-05	0.000294	CcSEcCtD
Mirtazapine—Nervous system disorder—Epirubicin—pancreatic cancer	9.98e-05	0.000293	CcSEcCtD
Mirtazapine—Dizziness—Docetaxel—pancreatic cancer	9.97e-05	0.000293	CcSEcCtD
Mirtazapine—Thrombocytopenia—Epirubicin—pancreatic cancer	9.96e-05	0.000293	CcSEcCtD
Mirtazapine—Hypertension—Doxorubicin—pancreatic cancer	9.96e-05	0.000293	CcSEcCtD
Mirtazapine—Tachycardia—Epirubicin—pancreatic cancer	9.93e-05	0.000292	CcSEcCtD
Mirtazapine—Skin disorder—Epirubicin—pancreatic cancer	9.88e-05	0.00029	CcSEcCtD
Mirtazapine—Hyperhidrosis—Epirubicin—pancreatic cancer	9.84e-05	0.000289	CcSEcCtD
Mirtazapine—Chest pain—Doxorubicin—pancreatic cancer	9.82e-05	0.000289	CcSEcCtD
Mirtazapine—Myalgia—Doxorubicin—pancreatic cancer	9.82e-05	0.000289	CcSEcCtD
Mirtazapine—Arthralgia—Doxorubicin—pancreatic cancer	9.82e-05	0.000289	CcSEcCtD
Mirtazapine—Anxiety—Doxorubicin—pancreatic cancer	9.79e-05	0.000288	CcSEcCtD
Mirtazapine—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—pancreatic cancer	9.75e-05	0.000287	CcSEcCtD
Mirtazapine—Discomfort—Doxorubicin—pancreatic cancer	9.7e-05	0.000285	CcSEcCtD
Mirtazapine—Anorexia—Epirubicin—pancreatic cancer	9.7e-05	0.000285	CcSEcCtD
Mirtazapine—Dry mouth—Doxorubicin—pancreatic cancer	9.6e-05	0.000282	CcSEcCtD
Mirtazapine—Vomiting—Docetaxel—pancreatic cancer	9.59e-05	0.000282	CcSEcCtD
Mirtazapine—Rash—Docetaxel—pancreatic cancer	9.51e-05	0.000279	CcSEcCtD
Mirtazapine—Hypotension—Epirubicin—pancreatic cancer	9.51e-05	0.000279	CcSEcCtD
Mirtazapine—Dermatitis—Docetaxel—pancreatic cancer	9.5e-05	0.000279	CcSEcCtD
Mirtazapine—Confusional state—Doxorubicin—pancreatic cancer	9.49e-05	0.000279	CcSEcCtD
Mirtazapine—Headache—Docetaxel—pancreatic cancer	9.45e-05	0.000278	CcSEcCtD
Mirtazapine—Oedema—Doxorubicin—pancreatic cancer	9.41e-05	0.000277	CcSEcCtD
Mirtazapine—Infection—Doxorubicin—pancreatic cancer	9.35e-05	0.000275	CcSEcCtD
Mirtazapine—Musculoskeletal discomfort—Epirubicin—pancreatic cancer	9.27e-05	0.000272	CcSEcCtD
Mirtazapine—Shock—Doxorubicin—pancreatic cancer	9.26e-05	0.000272	CcSEcCtD
Mirtazapine—Nervous system disorder—Doxorubicin—pancreatic cancer	9.23e-05	0.000271	CcSEcCtD
Mirtazapine—Thrombocytopenia—Doxorubicin—pancreatic cancer	9.22e-05	0.000271	CcSEcCtD
Mirtazapine—Insomnia—Epirubicin—pancreatic cancer	9.2e-05	0.00027	CcSEcCtD
Mirtazapine—Tachycardia—Doxorubicin—pancreatic cancer	9.19e-05	0.00027	CcSEcCtD
Mirtazapine—Skin disorder—Doxorubicin—pancreatic cancer	9.14e-05	0.000269	CcSEcCtD
Mirtazapine—Paraesthesia—Epirubicin—pancreatic cancer	9.14e-05	0.000268	CcSEcCtD
Mirtazapine—Hyperhidrosis—Doxorubicin—pancreatic cancer	9.1e-05	0.000267	CcSEcCtD
Mirtazapine—Dyspnoea—Epirubicin—pancreatic cancer	9.07e-05	0.000267	CcSEcCtD
Mirtazapine—Somnolence—Epirubicin—pancreatic cancer	9.04e-05	0.000266	CcSEcCtD
Mirtazapine—Anorexia—Doxorubicin—pancreatic cancer	8.97e-05	0.000264	CcSEcCtD
Mirtazapine—Nausea—Docetaxel—pancreatic cancer	8.96e-05	0.000263	CcSEcCtD
Mirtazapine—Dyspepsia—Epirubicin—pancreatic cancer	8.96e-05	0.000263	CcSEcCtD
Mirtazapine—Decreased appetite—Epirubicin—pancreatic cancer	8.84e-05	0.00026	CcSEcCtD
Mirtazapine—Hypotension—Doxorubicin—pancreatic cancer	8.8e-05	0.000258	CcSEcCtD
Mirtazapine—Gastrointestinal disorder—Epirubicin—pancreatic cancer	8.78e-05	0.000258	CcSEcCtD
Mirtazapine—Fatigue—Epirubicin—pancreatic cancer	8.77e-05	0.000258	CcSEcCtD
Mirtazapine—Pain—Epirubicin—pancreatic cancer	8.7e-05	0.000256	CcSEcCtD
Mirtazapine—Constipation—Epirubicin—pancreatic cancer	8.7e-05	0.000256	CcSEcCtD
Mirtazapine—Musculoskeletal discomfort—Doxorubicin—pancreatic cancer	8.58e-05	0.000252	CcSEcCtD
Mirtazapine—Insomnia—Doxorubicin—pancreatic cancer	8.51e-05	0.00025	CcSEcCtD
Mirtazapine—Paraesthesia—Doxorubicin—pancreatic cancer	8.45e-05	0.000248	CcSEcCtD
Mirtazapine—Dyspnoea—Doxorubicin—pancreatic cancer	8.39e-05	0.000247	CcSEcCtD
Mirtazapine—Feeling abnormal—Epirubicin—pancreatic cancer	8.38e-05	0.000246	CcSEcCtD
Mirtazapine—Somnolence—Doxorubicin—pancreatic cancer	8.37e-05	0.000246	CcSEcCtD
Mirtazapine—Gastrointestinal pain—Epirubicin—pancreatic cancer	8.32e-05	0.000244	CcSEcCtD
Mirtazapine—Dyspepsia—Doxorubicin—pancreatic cancer	8.29e-05	0.000243	CcSEcCtD
Mirtazapine—Decreased appetite—Doxorubicin—pancreatic cancer	8.18e-05	0.00024	CcSEcCtD
Mirtazapine—Gastrointestinal disorder—Doxorubicin—pancreatic cancer	8.13e-05	0.000239	CcSEcCtD
Mirtazapine—Fatigue—Doxorubicin—pancreatic cancer	8.12e-05	0.000238	CcSEcCtD
Mirtazapine—Urticaria—Epirubicin—pancreatic cancer	8.08e-05	0.000238	CcSEcCtD
Mirtazapine—Pain—Doxorubicin—pancreatic cancer	8.05e-05	0.000237	CcSEcCtD
Mirtazapine—Constipation—Doxorubicin—pancreatic cancer	8.05e-05	0.000237	CcSEcCtD
Mirtazapine—Abdominal pain—Epirubicin—pancreatic cancer	8.04e-05	0.000236	CcSEcCtD
Mirtazapine—Body temperature increased—Epirubicin—pancreatic cancer	8.04e-05	0.000236	CcSEcCtD
Mirtazapine—Feeling abnormal—Doxorubicin—pancreatic cancer	7.76e-05	0.000228	CcSEcCtD
Mirtazapine—Gastrointestinal pain—Doxorubicin—pancreatic cancer	7.7e-05	0.000226	CcSEcCtD
Mirtazapine—Hypersensitivity—Epirubicin—pancreatic cancer	7.5e-05	0.00022	CcSEcCtD
Mirtazapine—Urticaria—Doxorubicin—pancreatic cancer	7.48e-05	0.00022	CcSEcCtD
Mirtazapine—Body temperature increased—Doxorubicin—pancreatic cancer	7.44e-05	0.000219	CcSEcCtD
Mirtazapine—Abdominal pain—Doxorubicin—pancreatic cancer	7.44e-05	0.000219	CcSEcCtD
Mirtazapine—Asthenia—Epirubicin—pancreatic cancer	7.3e-05	0.000214	CcSEcCtD
Mirtazapine—Pruritus—Epirubicin—pancreatic cancer	7.2e-05	0.000212	CcSEcCtD
Mirtazapine—Diarrhoea—Epirubicin—pancreatic cancer	6.96e-05	0.000205	CcSEcCtD
Mirtazapine—Hypersensitivity—Doxorubicin—pancreatic cancer	6.94e-05	0.000204	CcSEcCtD
Mirtazapine—Asthenia—Doxorubicin—pancreatic cancer	6.75e-05	0.000198	CcSEcCtD
Mirtazapine—Dizziness—Epirubicin—pancreatic cancer	6.73e-05	0.000198	CcSEcCtD
Mirtazapine—Pruritus—Doxorubicin—pancreatic cancer	6.66e-05	0.000196	CcSEcCtD
Mirtazapine—Vomiting—Epirubicin—pancreatic cancer	6.47e-05	0.00019	CcSEcCtD
Mirtazapine—Diarrhoea—Doxorubicin—pancreatic cancer	6.44e-05	0.000189	CcSEcCtD
Mirtazapine—Rash—Epirubicin—pancreatic cancer	6.41e-05	0.000188	CcSEcCtD
Mirtazapine—Dermatitis—Epirubicin—pancreatic cancer	6.41e-05	0.000188	CcSEcCtD
Mirtazapine—Headache—Epirubicin—pancreatic cancer	6.37e-05	0.000187	CcSEcCtD
Mirtazapine—Dizziness—Doxorubicin—pancreatic cancer	6.23e-05	0.000183	CcSEcCtD
Mirtazapine—Nausea—Epirubicin—pancreatic cancer	6.04e-05	0.000178	CcSEcCtD
Mirtazapine—Vomiting—Doxorubicin—pancreatic cancer	5.99e-05	0.000176	CcSEcCtD
Mirtazapine—Rash—Doxorubicin—pancreatic cancer	5.94e-05	0.000174	CcSEcCtD
Mirtazapine—Dermatitis—Doxorubicin—pancreatic cancer	5.93e-05	0.000174	CcSEcCtD
Mirtazapine—Headache—Doxorubicin—pancreatic cancer	5.9e-05	0.000173	CcSEcCtD
Mirtazapine—Nausea—Doxorubicin—pancreatic cancer	5.59e-05	0.000164	CcSEcCtD
Mirtazapine—HTR2C—Signaling Pathways—PTEN—pancreatic cancer	6.48e-06	3.02e-05	CbGpPWpGaD
Mirtazapine—ADRA2C—Signaling Pathways—CTNNB1—pancreatic cancer	6.46e-06	3.01e-05	CbGpPWpGaD
Mirtazapine—DRD4—Signaling Pathways—KRAS—pancreatic cancer	6.46e-06	3.01e-05	CbGpPWpGaD
Mirtazapine—CYP2C8—Metabolism—PIK3CD—pancreatic cancer	6.45e-06	3.01e-05	CbGpPWpGaD
Mirtazapine—ADRA1A—Signaling Pathways—PIK3CB—pancreatic cancer	6.37e-06	2.97e-05	CbGpPWpGaD
Mirtazapine—DRD2—Signaling Pathways—CXCL8—pancreatic cancer	6.36e-06	2.96e-05	CbGpPWpGaD
Mirtazapine—HTR1A—Signaling by GPCR—AKT1—pancreatic cancer	6.35e-06	2.96e-05	CbGpPWpGaD
Mirtazapine—ADRA2C—Signaling Pathways—MMP9—pancreatic cancer	6.34e-06	2.96e-05	CbGpPWpGaD
Mirtazapine—HTR2C—Signaling by GPCR—AKT1—pancreatic cancer	6.32e-06	2.95e-05	CbGpPWpGaD
Mirtazapine—DRD2—Signaling by GPCR—HRAS—pancreatic cancer	6.32e-06	2.95e-05	CbGpPWpGaD
Mirtazapine—ADRB1—Signaling Pathways—SRC—pancreatic cancer	6.31e-06	2.94e-05	CbGpPWpGaD
Mirtazapine—ADRA2C—Signaling Pathways—PTEN—pancreatic cancer	6.3e-06	2.94e-05	CbGpPWpGaD
Mirtazapine—OPRK1—Signaling Pathways—PIK3CA—pancreatic cancer	6.3e-06	2.94e-05	CbGpPWpGaD
Mirtazapine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—pancreatic cancer	6.26e-06	2.92e-05	CbGpPWpGaD
Mirtazapine—HTR2A—Signaling Pathways—CXCL8—pancreatic cancer	6.26e-06	2.92e-05	CbGpPWpGaD
Mirtazapine—HRH1—Signaling Pathways—CXCL8—pancreatic cancer	6.24e-06	2.91e-05	CbGpPWpGaD
Mirtazapine—CYP3A4—Metabolism—STK11—pancreatic cancer	6.24e-06	2.91e-05	CbGpPWpGaD
Mirtazapine—HTR2A—Signaling by GPCR—HRAS—pancreatic cancer	6.21e-06	2.9e-05	CbGpPWpGaD
Mirtazapine—DRD3—Signaling Pathways—MYC—pancreatic cancer	6.21e-06	2.9e-05	CbGpPWpGaD
Mirtazapine—HRH1—Signaling by GPCR—HRAS—pancreatic cancer	6.2e-06	2.89e-05	CbGpPWpGaD
Mirtazapine—HTR7—Signaling Pathways—PIK3CA—pancreatic cancer	6.2e-06	2.89e-05	CbGpPWpGaD
Mirtazapine—DRD3—Signaling Pathways—TGFB1—pancreatic cancer	6.19e-06	2.89e-05	CbGpPWpGaD
Mirtazapine—ADRB2—Signaling Pathways—SRC—pancreatic cancer	6.18e-06	2.88e-05	CbGpPWpGaD
Mirtazapine—HTR2B—Signaling Pathways—KRAS—pancreatic cancer	6.17e-06	2.88e-05	CbGpPWpGaD
Mirtazapine—ADRB1—Signaling Pathways—VEGFA—pancreatic cancer	6.15e-06	2.87e-05	CbGpPWpGaD
Mirtazapine—ADRA2C—Signaling by GPCR—AKT1—pancreatic cancer	6.15e-06	2.87e-05	CbGpPWpGaD
Mirtazapine—DRD2—GPCR downstream signaling—AKT1—pancreatic cancer	6.14e-06	2.86e-05	CbGpPWpGaD
Mirtazapine—ADRA1A—Signaling Pathways—CXCL8—pancreatic cancer	6.12e-06	2.86e-05	CbGpPWpGaD
Mirtazapine—ADRA2A—Metabolism—PTEN—pancreatic cancer	6.12e-06	2.85e-05	CbGpPWpGaD
Mirtazapine—ADRA2A—Signaling by GPCR—PIK3CA—pancreatic cancer	6.11e-06	2.85e-05	CbGpPWpGaD
Mirtazapine—OPRK1—Signaling Pathways—TP53—pancreatic cancer	6.09e-06	2.84e-05	CbGpPWpGaD
Mirtazapine—ADRB1—Signaling Pathways—STAT3—pancreatic cancer	6.09e-06	2.84e-05	CbGpPWpGaD
Mirtazapine—ADRA1A—Signaling by GPCR—HRAS—pancreatic cancer	6.09e-06	2.84e-05	CbGpPWpGaD
Mirtazapine—DRD2—Signaling Pathways—CASP3—pancreatic cancer	6.08e-06	2.84e-05	CbGpPWpGaD
Mirtazapine—ADRB1—Signaling Pathways—NRAS—pancreatic cancer	6.07e-06	2.83e-05	CbGpPWpGaD
Mirtazapine—DRD3—Signaling Pathways—EGFR—pancreatic cancer	6.07e-06	2.83e-05	CbGpPWpGaD
Mirtazapine—HTR2A—GPCR downstream signaling—AKT1—pancreatic cancer	6.04e-06	2.82e-05	CbGpPWpGaD
Mirtazapine—HTR1A—Signaling Pathways—SRC—pancreatic cancer	6.04e-06	2.82e-05	CbGpPWpGaD
Mirtazapine—HRH1—GPCR downstream signaling—AKT1—pancreatic cancer	6.03e-06	2.81e-05	CbGpPWpGaD
Mirtazapine—CYP2D6—Metabolism—PIK3CG—pancreatic cancer	6.02e-06	2.81e-05	CbGpPWpGaD
Mirtazapine—ADRB2—Signaling Pathways—VEGFA—pancreatic cancer	6.01e-06	2.8e-05	CbGpPWpGaD
Mirtazapine—HTR2C—Signaling Pathways—SRC—pancreatic cancer	6.01e-06	2.8e-05	CbGpPWpGaD
Mirtazapine—HTR7—Signaling Pathways—TP53—pancreatic cancer	6e-06	2.8e-05	CbGpPWpGaD
Mirtazapine—HTR2A—Signaling Pathways—CASP3—pancreatic cancer	5.99e-06	2.79e-05	CbGpPWpGaD
Mirtazapine—HRH1—Signaling Pathways—CASP3—pancreatic cancer	5.97e-06	2.79e-05	CbGpPWpGaD
Mirtazapine—CYP2C9—Metabolism—PIK3CG—pancreatic cancer	5.97e-06	2.78e-05	CbGpPWpGaD
Mirtazapine—ADRB2—Signaling Pathways—STAT3—pancreatic cancer	5.96e-06	2.78e-05	CbGpPWpGaD
Mirtazapine—ADRB2—Signaling Pathways—NRAS—pancreatic cancer	5.94e-06	2.77e-05	CbGpPWpGaD
Mirtazapine—DRD4—Signaling Pathways—PIK3CA—pancreatic cancer	5.93e-06	2.77e-05	CbGpPWpGaD
Mirtazapine—DRD2—Signaling Pathways—CCND1—pancreatic cancer	5.92e-06	2.76e-05	CbGpPWpGaD
Mirtazapine—ADRA2A—Signaling Pathways—PIK3CB—pancreatic cancer	5.92e-06	2.76e-05	CbGpPWpGaD
Mirtazapine—ADRA1A—GPCR downstream signaling—AKT1—pancreatic cancer	5.92e-06	2.76e-05	CbGpPWpGaD
Mirtazapine—HTR1A—Signaling Pathways—VEGFA—pancreatic cancer	5.88e-06	2.74e-05	CbGpPWpGaD
Mirtazapine—DRD2—Signaling Pathways—CTNNB1—pancreatic cancer	5.87e-06	2.74e-05	CbGpPWpGaD
Mirtazapine—ADRA1A—Signaling Pathways—CASP3—pancreatic cancer	5.86e-06	2.73e-05	CbGpPWpGaD
Mirtazapine—HTR2C—Signaling Pathways—VEGFA—pancreatic cancer	5.85e-06	2.73e-05	CbGpPWpGaD
Mirtazapine—ADRA2C—Signaling Pathways—SRC—pancreatic cancer	5.84e-06	2.72e-05	CbGpPWpGaD
Mirtazapine—HTR2A—Signaling Pathways—CCND1—pancreatic cancer	5.83e-06	2.72e-05	CbGpPWpGaD
Mirtazapine—OPRK1—Signaling Pathways—HRAS—pancreatic cancer	5.83e-06	2.72e-05	CbGpPWpGaD
Mirtazapine—HTR1A—Signaling Pathways—STAT3—pancreatic cancer	5.82e-06	2.72e-05	CbGpPWpGaD
Mirtazapine—HRH1—Signaling Pathways—CCND1—pancreatic cancer	5.82e-06	2.71e-05	CbGpPWpGaD
Mirtazapine—CYP2D6—Metabolism—PPARG—pancreatic cancer	5.81e-06	2.71e-05	CbGpPWpGaD
Mirtazapine—HTR1A—Signaling Pathways—NRAS—pancreatic cancer	5.81e-06	2.71e-05	CbGpPWpGaD
Mirtazapine—HTR2C—Signaling Pathways—STAT3—pancreatic cancer	5.79e-06	2.7e-05	CbGpPWpGaD
Mirtazapine—HTR2C—Signaling Pathways—NRAS—pancreatic cancer	5.78e-06	2.7e-05	CbGpPWpGaD
Mirtazapine—HTR2A—Signaling Pathways—CTNNB1—pancreatic cancer	5.77e-06	2.69e-05	CbGpPWpGaD
Mirtazapine—CYP2C9—Metabolism—PPARG—pancreatic cancer	5.76e-06	2.69e-05	CbGpPWpGaD
Mirtazapine—HRH1—Signaling Pathways—CTNNB1—pancreatic cancer	5.76e-06	2.69e-05	CbGpPWpGaD
Mirtazapine—DRD2—Signaling Pathways—MMP9—pancreatic cancer	5.75e-06	2.68e-05	CbGpPWpGaD
Mirtazapine—DRD4—Signaling Pathways—TP53—pancreatic cancer	5.74e-06	2.68e-05	CbGpPWpGaD
Mirtazapine—DRD3—Signaling Pathways—KRAS—pancreatic cancer	5.74e-06	2.68e-05	CbGpPWpGaD
Mirtazapine—HTR7—Signaling Pathways—HRAS—pancreatic cancer	5.73e-06	2.67e-05	CbGpPWpGaD
Mirtazapine—DRD2—Signaling Pathways—PTEN—pancreatic cancer	5.72e-06	2.67e-05	CbGpPWpGaD
Mirtazapine—ADRA1A—Signaling Pathways—CCND1—pancreatic cancer	5.71e-06	2.66e-05	CbGpPWpGaD
Mirtazapine—ADRA2A—Signaling Pathways—CXCL8—pancreatic cancer	5.69e-06	2.65e-05	CbGpPWpGaD
Mirtazapine—ADRA2C—Signaling Pathways—VEGFA—pancreatic cancer	5.69e-06	2.65e-05	CbGpPWpGaD
Mirtazapine—HTR2B—Signaling Pathways—PIK3CA—pancreatic cancer	5.66e-06	2.64e-05	CbGpPWpGaD
Mirtazapine—HTR2A—Signaling Pathways—MMP9—pancreatic cancer	5.66e-06	2.64e-05	CbGpPWpGaD
Mirtazapine—ADRB1—Signaling Pathways—MYC—pancreatic cancer	5.66e-06	2.64e-05	CbGpPWpGaD
Mirtazapine—ADRA2A—Signaling by GPCR—HRAS—pancreatic cancer	5.65e-06	2.64e-05	CbGpPWpGaD
Mirtazapine—CYP1A2—Metabolism—APOE—pancreatic cancer	5.65e-06	2.64e-05	CbGpPWpGaD
Mirtazapine—ADRA1A—Signaling Pathways—CTNNB1—pancreatic cancer	5.65e-06	2.64e-05	CbGpPWpGaD
Mirtazapine—HRH1—Signaling Pathways—MMP9—pancreatic cancer	5.65e-06	2.63e-05	CbGpPWpGaD
Mirtazapine—ADRB1—Signaling Pathways—TGFB1—pancreatic cancer	5.64e-06	2.63e-05	CbGpPWpGaD
Mirtazapine—ADRA2C—Signaling Pathways—STAT3—pancreatic cancer	5.63e-06	2.63e-05	CbGpPWpGaD
Mirtazapine—HTR2A—Signaling Pathways—PTEN—pancreatic cancer	5.62e-06	2.62e-05	CbGpPWpGaD
Mirtazapine—CYP2C8—Metabolism—PIK3CB—pancreatic cancer	5.62e-06	2.62e-05	CbGpPWpGaD
Mirtazapine—ADRA2C—Signaling Pathways—NRAS—pancreatic cancer	5.62e-06	2.62e-05	CbGpPWpGaD
Mirtazapine—HRH1—Signaling Pathways—PTEN—pancreatic cancer	5.61e-06	2.62e-05	CbGpPWpGaD
Mirtazapine—DRD2—Signaling by GPCR—AKT1—pancreatic cancer	5.58e-06	2.6e-05	CbGpPWpGaD
Mirtazapine—CYP2C8—Metabolism—PTGS2—pancreatic cancer	5.57e-06	2.6e-05	CbGpPWpGaD
Mirtazapine—ADRA1A—Signaling Pathways—MMP9—pancreatic cancer	5.54e-06	2.58e-05	CbGpPWpGaD
Mirtazapine—ADRB2—Signaling Pathways—MYC—pancreatic cancer	5.53e-06	2.58e-05	CbGpPWpGaD
Mirtazapine—ADRB1—Signaling Pathways—EGFR—pancreatic cancer	5.53e-06	2.58e-05	CbGpPWpGaD
Mirtazapine—ADRB2—Signaling Pathways—TGFB1—pancreatic cancer	5.52e-06	2.57e-05	CbGpPWpGaD
Mirtazapine—ADRA1A—Signaling Pathways—PTEN—pancreatic cancer	5.51e-06	2.57e-05	CbGpPWpGaD
Mirtazapine—ADRA2A—GPCR downstream signaling—AKT1—pancreatic cancer	5.5e-06	2.56e-05	CbGpPWpGaD
Mirtazapine—DRD4—Signaling Pathways—HRAS—pancreatic cancer	5.49e-06	2.56e-05	CbGpPWpGaD
Mirtazapine—HTR2A—Signaling by GPCR—AKT1—pancreatic cancer	5.49e-06	2.56e-05	CbGpPWpGaD
Mirtazapine—HTR2B—Signaling Pathways—TP53—pancreatic cancer	5.48e-06	2.56e-05	CbGpPWpGaD
Mirtazapine—HRH1—Signaling by GPCR—AKT1—pancreatic cancer	5.48e-06	2.55e-05	CbGpPWpGaD
Mirtazapine—ADRA2A—Signaling Pathways—CASP3—pancreatic cancer	5.45e-06	2.54e-05	CbGpPWpGaD
Mirtazapine—ADRB2—Signaling Pathways—EGFR—pancreatic cancer	5.41e-06	2.52e-05	CbGpPWpGaD
Mirtazapine—HTR1A—Signaling Pathways—MYC—pancreatic cancer	5.41e-06	2.52e-05	CbGpPWpGaD
Mirtazapine—HTR1A—Signaling Pathways—TGFB1—pancreatic cancer	5.4e-06	2.52e-05	CbGpPWpGaD
Mirtazapine—HTR2C—Signaling Pathways—MYC—pancreatic cancer	5.38e-06	2.51e-05	CbGpPWpGaD
Mirtazapine—ADRA1A—Signaling by GPCR—AKT1—pancreatic cancer	5.37e-06	2.51e-05	CbGpPWpGaD
Mirtazapine—HTR2C—Signaling Pathways—TGFB1—pancreatic cancer	5.37e-06	2.5e-05	CbGpPWpGaD
Mirtazapine—CYP3A4—Metabolism—TYMS—pancreatic cancer	5.37e-06	2.5e-05	CbGpPWpGaD
Mirtazapine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—pancreatic cancer	5.35e-06	2.5e-05	CbGpPWpGaD
Mirtazapine—ADRA2C—Metabolism—PIK3CA—pancreatic cancer	5.32e-06	2.48e-05	CbGpPWpGaD
Mirtazapine—ADRA2A—Signaling Pathways—CCND1—pancreatic cancer	5.3e-06	2.47e-05	CbGpPWpGaD
Mirtazapine—DRD2—Signaling Pathways—SRC—pancreatic cancer	5.3e-06	2.47e-05	CbGpPWpGaD
Mirtazapine—CYP2D6—Metabolism—PIK3CD—pancreatic cancer	5.29e-06	2.47e-05	CbGpPWpGaD
Mirtazapine—HTR1A—Signaling Pathways—EGFR—pancreatic cancer	5.29e-06	2.47e-05	CbGpPWpGaD
Mirtazapine—DRD3—Signaling Pathways—PIK3CA—pancreatic cancer	5.27e-06	2.46e-05	CbGpPWpGaD
Mirtazapine—HTR2C—Signaling Pathways—EGFR—pancreatic cancer	5.27e-06	2.46e-05	CbGpPWpGaD
Mirtazapine—ADRA2A—Signaling Pathways—CTNNB1—pancreatic cancer	5.25e-06	2.45e-05	CbGpPWpGaD
Mirtazapine—CYP2C9—Metabolism—PIK3CD—pancreatic cancer	5.25e-06	2.45e-05	CbGpPWpGaD
Mirtazapine—HTR2B—Signaling Pathways—HRAS—pancreatic cancer	5.24e-06	2.44e-05	CbGpPWpGaD
Mirtazapine—ADRA2C—Signaling Pathways—MYC—pancreatic cancer	5.24e-06	2.44e-05	CbGpPWpGaD
Mirtazapine—ADRB1—Signaling Pathways—KRAS—pancreatic cancer	5.23e-06	2.44e-05	CbGpPWpGaD
Mirtazapine—ADRA2C—Signaling Pathways—TGFB1—pancreatic cancer	5.22e-06	2.44e-05	CbGpPWpGaD
Mirtazapine—HTR2A—Signaling Pathways—SRC—pancreatic cancer	5.22e-06	2.43e-05	CbGpPWpGaD
Mirtazapine—HRH1—Signaling Pathways—SRC—pancreatic cancer	5.21e-06	2.43e-05	CbGpPWpGaD
Mirtazapine—DRD2—Signaling Pathways—VEGFA—pancreatic cancer	5.16e-06	2.41e-05	CbGpPWpGaD
Mirtazapine—ADRA2A—Signaling Pathways—MMP9—pancreatic cancer	5.15e-06	2.4e-05	CbGpPWpGaD
Mirtazapine—OPRK1—Signaling Pathways—AKT1—pancreatic cancer	5.14e-06	2.4e-05	CbGpPWpGaD
Mirtazapine—ADRA2C—Signaling Pathways—EGFR—pancreatic cancer	5.12e-06	2.39e-05	CbGpPWpGaD
Mirtazapine—ADRA2A—Signaling Pathways—PTEN—pancreatic cancer	5.12e-06	2.39e-05	CbGpPWpGaD
Mirtazapine—ADRB2—Signaling Pathways—KRAS—pancreatic cancer	5.11e-06	2.38e-05	CbGpPWpGaD
Mirtazapine—DRD2—Signaling Pathways—STAT3—pancreatic cancer	5.11e-06	2.38e-05	CbGpPWpGaD
Mirtazapine—ADRA1A—Signaling Pathways—SRC—pancreatic cancer	5.11e-06	2.38e-05	CbGpPWpGaD
Mirtazapine—CYP1A2—Metabolism—PIK3CG—pancreatic cancer	5.1e-06	2.38e-05	CbGpPWpGaD
Mirtazapine—DRD2—Signaling Pathways—NRAS—pancreatic cancer	5.1e-06	2.38e-05	CbGpPWpGaD
Mirtazapine—DRD3—Signaling Pathways—TP53—pancreatic cancer	5.1e-06	2.38e-05	CbGpPWpGaD
Mirtazapine—HTR2A—Signaling Pathways—VEGFA—pancreatic cancer	5.08e-06	2.37e-05	CbGpPWpGaD
Mirtazapine—HRH1—Signaling Pathways—VEGFA—pancreatic cancer	5.07e-06	2.36e-05	CbGpPWpGaD
Mirtazapine—HTR7—Signaling Pathways—AKT1—pancreatic cancer	5.06e-06	2.36e-05	CbGpPWpGaD
Mirtazapine—HTR2A—Signaling Pathways—STAT3—pancreatic cancer	5.03e-06	2.35e-05	CbGpPWpGaD
Mirtazapine—HRH1—Signaling Pathways—STAT3—pancreatic cancer	5.02e-06	2.34e-05	CbGpPWpGaD
Mirtazapine—HTR2A—Signaling Pathways—NRAS—pancreatic cancer	5.02e-06	2.34e-05	CbGpPWpGaD
Mirtazapine—HRH1—Signaling Pathways—NRAS—pancreatic cancer	5.01e-06	2.34e-05	CbGpPWpGaD
Mirtazapine—HTR1A—Signaling Pathways—KRAS—pancreatic cancer	5e-06	2.33e-05	CbGpPWpGaD
Mirtazapine—ADRA2A—Signaling by GPCR—AKT1—pancreatic cancer	4.99e-06	2.33e-05	CbGpPWpGaD
Mirtazapine—ADRA1A—Signaling Pathways—VEGFA—pancreatic cancer	4.97e-06	2.32e-05	CbGpPWpGaD
Mirtazapine—HTR2C—Signaling Pathways—KRAS—pancreatic cancer	4.97e-06	2.32e-05	CbGpPWpGaD
Mirtazapine—ADRA1A—Signaling Pathways—STAT3—pancreatic cancer	4.93e-06	2.3e-05	CbGpPWpGaD
Mirtazapine—CYP1A2—Metabolism—PPARG—pancreatic cancer	4.92e-06	2.3e-05	CbGpPWpGaD
Mirtazapine—ADRA1A—Signaling Pathways—NRAS—pancreatic cancer	4.91e-06	2.29e-05	CbGpPWpGaD
Mirtazapine—DRD3—Signaling Pathways—HRAS—pancreatic cancer	4.88e-06	2.27e-05	CbGpPWpGaD
Mirtazapine—CYP2C8—Metabolism—PTEN—pancreatic cancer	4.86e-06	2.27e-05	CbGpPWpGaD
Mirtazapine—DRD4—Signaling Pathways—AKT1—pancreatic cancer	4.85e-06	2.26e-05	CbGpPWpGaD
Mirtazapine—ADRA2C—Signaling Pathways—KRAS—pancreatic cancer	4.84e-06	2.26e-05	CbGpPWpGaD
Mirtazapine—ADRB1—Signaling Pathways—PIK3CA—pancreatic cancer	4.8e-06	2.24e-05	CbGpPWpGaD
Mirtazapine—DRD2—Signaling Pathways—MYC—pancreatic cancer	4.75e-06	2.22e-05	CbGpPWpGaD
Mirtazapine—ADRA2A—Signaling Pathways—SRC—pancreatic cancer	4.75e-06	2.21e-05	CbGpPWpGaD
Mirtazapine—DRD2—Signaling Pathways—TGFB1—pancreatic cancer	4.74e-06	2.21e-05	CbGpPWpGaD
Mirtazapine—ADRB2—Signaling Pathways—PIK3CA—pancreatic cancer	4.7e-06	2.19e-05	CbGpPWpGaD
Mirtazapine—HTR2A—Signaling Pathways—MYC—pancreatic cancer	4.67e-06	2.18e-05	CbGpPWpGaD
Mirtazapine—HRH1—Signaling Pathways—MYC—pancreatic cancer	4.66e-06	2.18e-05	CbGpPWpGaD
Mirtazapine—HTR2A—Signaling Pathways—TGFB1—pancreatic cancer	4.66e-06	2.17e-05	CbGpPWpGaD
Mirtazapine—HRH1—Signaling Pathways—TGFB1—pancreatic cancer	4.65e-06	2.17e-05	CbGpPWpGaD
Mirtazapine—DRD2—Signaling Pathways—EGFR—pancreatic cancer	4.65e-06	2.17e-05	CbGpPWpGaD
Mirtazapine—ADRB1—Signaling Pathways—TP53—pancreatic cancer	4.65e-06	2.17e-05	CbGpPWpGaD
Mirtazapine—HTR2B—Signaling Pathways—AKT1—pancreatic cancer	4.63e-06	2.16e-05	CbGpPWpGaD
Mirtazapine—ADRA2A—Signaling Pathways—VEGFA—pancreatic cancer	4.62e-06	2.16e-05	CbGpPWpGaD
Mirtazapine—CYP2D6—Metabolism—PIK3CB—pancreatic cancer	4.62e-06	2.15e-05	CbGpPWpGaD
Mirtazapine—HTR1A—Signaling Pathways—PIK3CA—pancreatic cancer	4.59e-06	2.14e-05	CbGpPWpGaD
Mirtazapine—ADRA1A—Signaling Pathways—MYC—pancreatic cancer	4.58e-06	2.13e-05	CbGpPWpGaD
Mirtazapine—ADRA2A—Signaling Pathways—STAT3—pancreatic cancer	4.58e-06	2.13e-05	CbGpPWpGaD
Mirtazapine—CYP2C9—Metabolism—PIK3CB—pancreatic cancer	4.58e-06	2.13e-05	CbGpPWpGaD
Mirtazapine—CYP2D6—Metabolism—PTGS2—pancreatic cancer	4.57e-06	2.13e-05	CbGpPWpGaD
Mirtazapine—HTR2A—Signaling Pathways—EGFR—pancreatic cancer	4.57e-06	2.13e-05	CbGpPWpGaD
Mirtazapine—HTR2C—Signaling Pathways—PIK3CA—pancreatic cancer	4.57e-06	2.13e-05	CbGpPWpGaD
Mirtazapine—ADRA1A—Signaling Pathways—TGFB1—pancreatic cancer	4.57e-06	2.13e-05	CbGpPWpGaD
Mirtazapine—ADRA2A—Signaling Pathways—NRAS—pancreatic cancer	4.57e-06	2.13e-05	CbGpPWpGaD
Mirtazapine—HRH1—Signaling Pathways—EGFR—pancreatic cancer	4.56e-06	2.13e-05	CbGpPWpGaD
Mirtazapine—ADRB2—Signaling Pathways—TP53—pancreatic cancer	4.54e-06	2.12e-05	CbGpPWpGaD
Mirtazapine—CYP2C9—Metabolism—PTGS2—pancreatic cancer	4.53e-06	2.11e-05	CbGpPWpGaD
Mirtazapine—CYP1A2—Metabolism—PIK3CD—pancreatic cancer	4.49e-06	2.09e-05	CbGpPWpGaD
Mirtazapine—ADRA1A—Signaling Pathways—EGFR—pancreatic cancer	4.48e-06	2.09e-05	CbGpPWpGaD
Mirtazapine—ADRA2C—Signaling Pathways—PIK3CA—pancreatic cancer	4.44e-06	2.07e-05	CbGpPWpGaD
Mirtazapine—HTR1A—Signaling Pathways—TP53—pancreatic cancer	4.44e-06	2.07e-05	CbGpPWpGaD
Mirtazapine—ADRB1—Signaling Pathways—HRAS—pancreatic cancer	4.44e-06	2.07e-05	CbGpPWpGaD
Mirtazapine—HTR2C—Signaling Pathways—TP53—pancreatic cancer	4.42e-06	2.06e-05	CbGpPWpGaD
Mirtazapine—DRD2—Signaling Pathways—KRAS—pancreatic cancer	4.39e-06	2.05e-05	CbGpPWpGaD
Mirtazapine—CYP3A4—Metabolism—APOE—pancreatic cancer	4.36e-06	2.03e-05	CbGpPWpGaD
Mirtazapine—ADRB2—Signaling Pathways—HRAS—pancreatic cancer	4.35e-06	2.03e-05	CbGpPWpGaD
Mirtazapine—ADRA2C—Metabolism—AKT1—pancreatic cancer	4.34e-06	2.03e-05	CbGpPWpGaD
Mirtazapine—HTR2A—Signaling Pathways—KRAS—pancreatic cancer	4.32e-06	2.01e-05	CbGpPWpGaD
Mirtazapine—ADRA2A—Metabolism—PIK3CA—pancreatic cancer	4.32e-06	2.01e-05	CbGpPWpGaD
Mirtazapine—HRH1—Signaling Pathways—KRAS—pancreatic cancer	4.31e-06	2.01e-05	CbGpPWpGaD
Mirtazapine—DRD3—Signaling Pathways—AKT1—pancreatic cancer	4.31e-06	2.01e-05	CbGpPWpGaD
Mirtazapine—ADRA2C—Signaling Pathways—TP53—pancreatic cancer	4.3e-06	2.01e-05	CbGpPWpGaD
Mirtazapine—ADRA2A—Signaling Pathways—MYC—pancreatic cancer	4.25e-06	1.98e-05	CbGpPWpGaD
Mirtazapine—HTR1A—Signaling Pathways—HRAS—pancreatic cancer	4.25e-06	1.98e-05	CbGpPWpGaD
Mirtazapine—ADRA2A—Signaling Pathways—TGFB1—pancreatic cancer	4.24e-06	1.98e-05	CbGpPWpGaD
Mirtazapine—ADRA1A—Signaling Pathways—KRAS—pancreatic cancer	4.23e-06	1.97e-05	CbGpPWpGaD
Mirtazapine—HTR2C—Signaling Pathways—HRAS—pancreatic cancer	4.23e-06	1.97e-05	CbGpPWpGaD
Mirtazapine—ADRA2A—Signaling Pathways—EGFR—pancreatic cancer	4.16e-06	1.94e-05	CbGpPWpGaD
Mirtazapine—ADRA2C—Signaling Pathways—HRAS—pancreatic cancer	4.11e-06	1.92e-05	CbGpPWpGaD
Mirtazapine—DRD2—Signaling Pathways—PIK3CA—pancreatic cancer	4.03e-06	1.88e-05	CbGpPWpGaD
Mirtazapine—CYP2D6—Metabolism—PTEN—pancreatic cancer	3.99e-06	1.86e-05	CbGpPWpGaD
Mirtazapine—HTR2A—Signaling Pathways—PIK3CA—pancreatic cancer	3.97e-06	1.85e-05	CbGpPWpGaD
Mirtazapine—HRH1—Signaling Pathways—PIK3CA—pancreatic cancer	3.96e-06	1.85e-05	CbGpPWpGaD
Mirtazapine—CYP2C9—Metabolism—PTEN—pancreatic cancer	3.95e-06	1.84e-05	CbGpPWpGaD
Mirtazapine—CYP3A4—Metabolism—PIK3CG—pancreatic cancer	3.94e-06	1.84e-05	CbGpPWpGaD
Mirtazapine—ADRA2A—Signaling Pathways—KRAS—pancreatic cancer	3.93e-06	1.83e-05	CbGpPWpGaD
Mirtazapine—ADRB1—Signaling Pathways—AKT1—pancreatic cancer	3.92e-06	1.83e-05	CbGpPWpGaD
Mirtazapine—CYP1A2—Metabolism—PIK3CB—pancreatic cancer	3.91e-06	1.82e-05	CbGpPWpGaD
Mirtazapine—DRD2—Signaling Pathways—TP53—pancreatic cancer	3.9e-06	1.82e-05	CbGpPWpGaD
Mirtazapine—ADRA1A—Signaling Pathways—PIK3CA—pancreatic cancer	3.89e-06	1.81e-05	CbGpPWpGaD
Mirtazapine—CYP1A2—Metabolism—PTGS2—pancreatic cancer	3.87e-06	1.81e-05	CbGpPWpGaD
Mirtazapine—HTR2A—Signaling Pathways—TP53—pancreatic cancer	3.84e-06	1.79e-05	CbGpPWpGaD
Mirtazapine—ADRB2—Signaling Pathways—AKT1—pancreatic cancer	3.84e-06	1.79e-05	CbGpPWpGaD
Mirtazapine—HRH1—Signaling Pathways—TP53—pancreatic cancer	3.83e-06	1.79e-05	CbGpPWpGaD
Mirtazapine—CYP3A4—Metabolism—PPARG—pancreatic cancer	3.8e-06	1.77e-05	CbGpPWpGaD
Mirtazapine—ADRA1A—Signaling Pathways—TP53—pancreatic cancer	3.76e-06	1.75e-05	CbGpPWpGaD
Mirtazapine—HTR1A—Signaling Pathways—AKT1—pancreatic cancer	3.75e-06	1.75e-05	CbGpPWpGaD
Mirtazapine—HTR2C—Signaling Pathways—AKT1—pancreatic cancer	3.73e-06	1.74e-05	CbGpPWpGaD
Mirtazapine—DRD2—Signaling Pathways—HRAS—pancreatic cancer	3.73e-06	1.74e-05	CbGpPWpGaD
Mirtazapine—HTR2A—Signaling Pathways—HRAS—pancreatic cancer	3.67e-06	1.71e-05	CbGpPWpGaD
Mirtazapine—HRH1—Signaling Pathways—HRAS—pancreatic cancer	3.66e-06	1.71e-05	CbGpPWpGaD
Mirtazapine—ADRA2C—Signaling Pathways—AKT1—pancreatic cancer	3.63e-06	1.69e-05	CbGpPWpGaD
Mirtazapine—ADRA2A—Signaling Pathways—PIK3CA—pancreatic cancer	3.61e-06	1.68e-05	CbGpPWpGaD
Mirtazapine—ADRA1A—Signaling Pathways—HRAS—pancreatic cancer	3.59e-06	1.68e-05	CbGpPWpGaD
Mirtazapine—ADRA2A—Metabolism—AKT1—pancreatic cancer	3.53e-06	1.64e-05	CbGpPWpGaD
Mirtazapine—ADRA2A—Signaling Pathways—TP53—pancreatic cancer	3.49e-06	1.63e-05	CbGpPWpGaD
Mirtazapine—CYP3A4—Metabolism—PIK3CD—pancreatic cancer	3.46e-06	1.61e-05	CbGpPWpGaD
Mirtazapine—CYP2C8—Metabolism—PIK3CA—pancreatic cancer	3.43e-06	1.6e-05	CbGpPWpGaD
Mirtazapine—CYP1A2—Metabolism—PTEN—pancreatic cancer	3.38e-06	1.58e-05	CbGpPWpGaD
Mirtazapine—ADRA2A—Signaling Pathways—HRAS—pancreatic cancer	3.34e-06	1.56e-05	CbGpPWpGaD
Mirtazapine—DRD2—Signaling Pathways—AKT1—pancreatic cancer	3.29e-06	1.54e-05	CbGpPWpGaD
Mirtazapine—HTR2A—Signaling Pathways—AKT1—pancreatic cancer	3.24e-06	1.51e-05	CbGpPWpGaD
Mirtazapine—HRH1—Signaling Pathways—AKT1—pancreatic cancer	3.23e-06	1.51e-05	CbGpPWpGaD
Mirtazapine—ADRA1A—Signaling Pathways—AKT1—pancreatic cancer	3.17e-06	1.48e-05	CbGpPWpGaD
Mirtazapine—CYP3A4—Metabolism—PIK3CB—pancreatic cancer	3.02e-06	1.41e-05	CbGpPWpGaD
Mirtazapine—CYP3A4—Metabolism—PTGS2—pancreatic cancer	2.99e-06	1.39e-05	CbGpPWpGaD
Mirtazapine—ADRA2A—Signaling Pathways—AKT1—pancreatic cancer	2.95e-06	1.38e-05	CbGpPWpGaD
Mirtazapine—CYP2D6—Metabolism—PIK3CA—pancreatic cancer	2.81e-06	1.31e-05	CbGpPWpGaD
Mirtazapine—CYP2C8—Metabolism—AKT1—pancreatic cancer	2.8e-06	1.31e-05	CbGpPWpGaD
Mirtazapine—CYP2C9—Metabolism—PIK3CA—pancreatic cancer	2.79e-06	1.3e-05	CbGpPWpGaD
Mirtazapine—CYP3A4—Metabolism—PTEN—pancreatic cancer	2.61e-06	1.22e-05	CbGpPWpGaD
Mirtazapine—CYP1A2—Metabolism—PIK3CA—pancreatic cancer	2.38e-06	1.11e-05	CbGpPWpGaD
Mirtazapine—CYP2D6—Metabolism—AKT1—pancreatic cancer	2.3e-06	1.07e-05	CbGpPWpGaD
Mirtazapine—CYP2C9—Metabolism—AKT1—pancreatic cancer	2.28e-06	1.06e-05	CbGpPWpGaD
Mirtazapine—CYP1A2—Metabolism—AKT1—pancreatic cancer	1.95e-06	9.08e-06	CbGpPWpGaD
Mirtazapine—CYP3A4—Metabolism—PIK3CA—pancreatic cancer	1.84e-06	8.58e-06	CbGpPWpGaD
Mirtazapine—CYP3A4—Metabolism—AKT1—pancreatic cancer	1.5e-06	7.01e-06	CbGpPWpGaD
